ACCESS THE LATEST RESEARCH AND INSIGHTS
MEDEXUS PHARMACEUTICALS CEO INTERVIEW THIS WEEK
We’ll post our interview this week with Ken d’Entremont, CEO of Medexus Pharmaceuticals, a specialty pharma company with strong growth and $27 million in cash.
MEDEXUS PHARMACEUTICALS CEO INTERVIEW THIS WEEK
We’ll post our interview this week with Ken d’Entremont, CEO of Medexus Pharmaceuticals, a specialty pharma company with strong growth and $27 million in cash.
NINE TOP PICKS & MY DEEP DIVE ON ARITZIA ;-)
Access the new Digest to find out how an equities research team has grown its small cap portfolio by 80%+ the last three years.
NINE TOP PICKS & MY DEEP DIVE ON ARITZIA ;-)
Access the new Digest to find out how an equities research team has grown its small cap portfolio by 80%+ the last three years.
Up 28% This Year, Nine Top Picks from Outperforming Portfolio
Let the Pros Do the Work. Nine Top Picks from Portfolio Up 82% Since Inception.
Up 28% This Year, Nine Top Picks from Outperforming Portfolio
Let the Pros Do the Work. Nine Top Picks from Portfolio Up 82% Since Inception.
TODAY’S DIGEST FEATURES TOP PICKS PORTFOLIO UP 82% SINCE INCEPTION
Nine small cap Top Picks from a research team whose portfolio is 82% higher since inception. Expect that in the new Capital Ideas Digest when it’s published today at 7 pm ET.
TODAY’S DIGEST FEATURES TOP PICKS PORTFOLIO UP 82% SINCE INCEPTION
Nine small cap Top Picks from a research team whose portfolio is 82% higher since inception. Expect that in the new Capital Ideas Digest when it’s published today at 7 pm ET.
“HIGH-GROWTH PURE PLAY IN EARLY INNINGS OF AGGRESSIVE EXPANSION”
Trisura Group is one of the seven high conviction stocks in the new Digest. Find out why GMP is high on this pure play.
“HIGH-GROWTH PURE PLAY IN EARLY INNINGS OF AGGRESSIVE EXPANSION”
Trisura Group is one of the seven high conviction stocks in the new Digest. Find out why GMP is high on this pure play.
TRISURA GROUP TAGGED AS HIGH CONVICTION STOCK
Access the new Capital Ideas Digest for neat research summaries on seven high conviction stocks from a cross-section of sectors that have the potential for at least 20% gains.
TRISURA GROUP TAGGED AS HIGH CONVICTION STOCK
Access the new Capital Ideas Digest for neat research summaries on seven high conviction stocks from a cross-section of sectors that have the potential for at least 20% gains.